1. Home
  2. DOLE vs SANA Comparison

DOLE vs SANA Comparison

Compare DOLE & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dole plc

DOLE

Dole plc

HOLD

Current Price

$14.65

Market Cap

1.2B

ML Signal

HOLD

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

HOLD

Current Price

$4.07

Market Cap

983.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOLE
SANA
Founded
1851
2018
Country
Ireland
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
983.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DOLE
SANA
Price
$14.65
$4.07
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$7.83
AVG Volume (30 Days)
1.1M
4.2M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
2.32%
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$8,974,210,000.00
N/A
Revenue This Year
$7.21
N/A
Revenue Next Year
$1.92
N/A
P/E Ratio
$97.62
N/A
Revenue Growth
7.09
N/A
52 Week Low
$12.20
$1.26
52 Week High
$15.36
$7.30

Technical Indicators

Market Signals
Indicator
DOLE
SANA
Relative Strength Index (RSI) 73.63 50.42
Support Level $13.49 $3.16
Resistance Level $14.16 $4.32
Average True Range (ATR) 0.34 0.37
MACD 0.08 0.05
Stochastic Oscillator 96.51 72.72

Price Performance

Historical Comparison
DOLE
SANA

About DOLE Dole plc

Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Share on Social Networks: